School of Medicine
Showing 3,841-3,850 of 4,711 Results
-
Run Zhang Shi
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsClinical chemistry and therapeutic drug monitoring;
adult and pediatric clinical endocrine testing;
screening, detection and follow up of multiple myeloma;
tumor markers;
clinical utility of tandem mass spectrometry and high resolution mass spectrometry. -
Vivian Shih, MD
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Vivian Shih received her Bachelor of Science with honors and Doctor of Medicine degree from the University of Miami. In 2002, she completed her postgraduate medical training in Physical Medicine and Rehabilitation at the Feinberg School of Medicine at Northwestern University and the Rehabilitation Institute of Chicago (Shirley Ryan Ability Lab). She is board certified in Physical Medicine and Rehabilitation (PM&R or Physiatry) and specializes in non-surgical management of musculoskeletal disorders, arthritis, gait and balance disorders. She also performs electrodiagnostic testing (EMG/NCS), ultrasound guided joint/soft tissue injections, and platelet rich plasma (PRP) injections. Dr. Shih previously practiced in the New Haven area from 2005 to 2018. She was an Attending Physician at Yale-New Haven Hospital and on faculty at the Yale School of Medicine. Prior to that, she had been practicing at Northwestern University Medical Center and the Rehabilitation Institute of Chicago. She has published in the Arthritis and Rheumatism journal, Academy of Physical Medicine & Rehabilitation (AAPM&R) online review, Archives of Physical Medicine and Rehabilitation journal, and Koopman's Arthritis and Allied Health textbook. She is a member of the AAPM&R, Association of Academic Physiatrists (AAP), and the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM).
-
Hiroyuki Shimada
Professor of Pathology and of Pediatrics
BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials. -
Andrew Young Shin
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsSURF PROGRAM
The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.
https://surf.stanford.edu/
CLINICAL EFFECTIVENESS
The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason.
